Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Itishree Kaushik"'
Autor:
Nehal Gupta, Shreyas Gaikwad, Itishree Kaushik, Stephen E. Wright, Maciej M. Markiewski, Sanjay K. Srivastava
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 10, p 5150 (2021)
A major contributing factor in triple-negative breast cancer progression is its ability to evade immune surveillance. One mechanism for this immunosuppression is through ribosomal protein S19 (RPS19), which facilitates myeloid-derived suppressor cell
Externí odkaz:
https://doaj.org/article/3ba2af4e1d5a4b52abb099f52a925b51
Publikováno v:
Cells, Vol 9, Iss 9, p 2141 (2020)
Brain tumors are considered as one of the most aggressive and incurable forms of cancer. The majority of the patients with brain tumors have a median survival rate of 12%. Brain tumors are lethal despite the availability of advanced treatment options
Externí odkaz:
https://doaj.org/article/73c49ef4d9ce44048138126d99b17661
Autor:
Alok Ranjan, Sharavan Ramachandran, Nehal Gupta, Itishree Kaushik, Stephen Wright, Suyash Srivastava, Hiranmoy Das, Sangeeta Srivastava, Sahdeo Prasad, Sanjay K. Srivastava
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 20, p 4981 (2019)
The use of synthetic, natural, or biological agents to minimize the occurrence of cancer in healthy individuals is defined as cancer chemoprevention. Chemopreventive agents inhibit the development of cancer either by impeding DNA damage, which leads
Externí odkaz:
https://doaj.org/article/01b6aeed952c4d5da7692f885e06abf1
Publikováno v:
Seminars in Cancer Biology. 86:491-498
Immune check point inhibitors (ICIs) have marked their existence in the field of cancer immunotherapy. Their existence dates to 2011 when the first anti-cytotoxic T lymphocyte-associated protein 4 (CTLA-4) got its FDA approval for the management of m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62277f044b0e34f8be8540b3022bf6d7
https://doi.org/10.1016/j.semcancer.2022.03.020
https://doi.org/10.1016/j.semcancer.2022.03.020
Autor:
Itishree Kaushik, Sanjay K. Srivastava
Publikováno v:
Mol Ther
The Sonic hedgehog-activated subgroup of medulloblastoma (SHH-MB) is one of the most common malignant pediatric brain tumors. Recent clinical studies and genomic databases indicate that GABA(A) receptor holds significant clinical relevance as a thera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47e8d38645e1a5804754bd4523f978d6
https://doi.org/10.1016/j.ymthe.2022.03.012
https://doi.org/10.1016/j.ymthe.2022.03.012
Publikováno v:
Semin Cancer Biol
Cancer continues to be one of the leading contributors towards global disease burden. According to NIH, cancer incidence rate per year will increase to 23.6 million by 2030. Even though cancer continues to be a major proportion of the disease burden
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::594973e54596f0c5f1ca6ab3326d0b34
https://doi.org/10.1016/j.semcancer.2020.03.011
https://doi.org/10.1016/j.semcancer.2020.03.011
Publikováno v:
Semin Cell Dev Biol
CRISPR-Cas9 is an RNA guided endonuclease that has revolutionized the ability to edit genome and introduce desired manipulations in the target genomic sequence. It is a flexible methodology and is capable of targeting multiple loci simultaneously. Ow
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cb0936b921762d86089fb069cd466a7
https://doi.org/10.1016/j.semcdb.2019.04.018
https://doi.org/10.1016/j.semcdb.2019.04.018
Publikováno v:
Cancer Research. 82:3895-3895
Pediatric glioblastoma multiforme (GBM) is considered to be the second most lethal childhood cancer type after leukemia. Recent preclinical, clinical and genomic studies have highlighted upon the role of Hippo-Yap pathway in the progression of pediat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a57a2eeab2955a4680a38faff0e380b
https://doi.org/10.1158/1538-7445.am2022-3895
https://doi.org/10.1158/1538-7445.am2022-3895
Autor:
Sanjay K. Srivastava, Itishree Kaushik
Publikováno v:
The FASEB Journal. 35
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a1822d89511f212bcb455ff4dea5343
https://doi.org/10.1096/fasebj.2021.35.s1.04322
https://doi.org/10.1096/fasebj.2021.35.s1.04322
Publikováno v:
Cells
Cells, Vol 9, Iss 2141, p 2141 (2020)
Cells; Volume 9; Issue 9; Pages: 2141
Cells, Vol 9, Iss 2141, p 2141 (2020)
Cells; Volume 9; Issue 9; Pages: 2141
Brain tumors are considered as one of the most aggressive and incurable forms of cancer. The majority of the patients with brain tumors have a median survival rate of 12%. Brain tumors are lethal despite the availability of advanced treatment options
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c356ac19fdf5b533703ffcee9b253fe
http://europepmc.org/articles/PMC7563195
http://europepmc.org/articles/PMC7563195